全文获取类型
收费全文 | 131452篇 |
免费 | 9878篇 |
国内免费 | 4355篇 |
专业分类
耳鼻咽喉 | 651篇 |
儿科学 | 2783篇 |
妇产科学 | 2328篇 |
基础医学 | 24839篇 |
口腔科学 | 2683篇 |
临床医学 | 10107篇 |
内科学 | 25773篇 |
皮肤病学 | 2352篇 |
神经病学 | 4545篇 |
特种医学 | 2078篇 |
外国民族医学 | 298篇 |
外科学 | 6951篇 |
综合类 | 18342篇 |
现状与发展 | 27篇 |
一般理论 | 29篇 |
预防医学 | 18763篇 |
眼科学 | 1472篇 |
药学 | 11484篇 |
36篇 | |
中国医学 | 3802篇 |
肿瘤学 | 6342篇 |
出版年
2024年 | 139篇 |
2023年 | 1405篇 |
2022年 | 3301篇 |
2021年 | 4255篇 |
2020年 | 3771篇 |
2019年 | 3676篇 |
2018年 | 3787篇 |
2017年 | 3825篇 |
2016年 | 4251篇 |
2015年 | 4491篇 |
2014年 | 10101篇 |
2013年 | 11503篇 |
2012年 | 8112篇 |
2011年 | 8770篇 |
2010年 | 9073篇 |
2009年 | 8382篇 |
2008年 | 6523篇 |
2007年 | 5830篇 |
2006年 | 5310篇 |
2005年 | 4486篇 |
2004年 | 4102篇 |
2003年 | 3656篇 |
2002年 | 3010篇 |
2001年 | 2764篇 |
2000年 | 2302篇 |
1999年 | 1983篇 |
1998年 | 1813篇 |
1997年 | 1824篇 |
1996年 | 1525篇 |
1995年 | 1495篇 |
1994年 | 1365篇 |
1993年 | 1194篇 |
1992年 | 988篇 |
1991年 | 894篇 |
1990年 | 712篇 |
1989年 | 655篇 |
1988年 | 594篇 |
1987年 | 428篇 |
1986年 | 366篇 |
1985年 | 651篇 |
1984年 | 498篇 |
1983年 | 351篇 |
1982年 | 376篇 |
1981年 | 292篇 |
1980年 | 223篇 |
1979年 | 156篇 |
1978年 | 155篇 |
1977年 | 99篇 |
1976年 | 93篇 |
1975年 | 40篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
31.
The enormous development in the field of molecular genetics during the last decades has lead to optimism concerning the possibilities for identifying the causes of multiple sclerosis (MS) through genetic studies. However, we have learned that dense mapping of large sample sets is needed, which only can be achieved through large collaborative studies. The contribution from each yet unidentified gene is probably weaker than that of the well established human leukocyte antigen association. The ultimate goal of the search for susceptibility genes in MS is to develop diagnostic tools and better treatments that can prevent or reduce the development of symptoms of this often devastating disease. 相似文献
32.
H. S. Pollinger M. D. Stegall J. M. Gloor S. B. Moore S. R. Degoey N. A. Ploeger W. D. Park H. S. Pollinger M. D. Stegall J. M. Gloor S. B. Moore S. R. Degoey N. A. Ploeger W. D. Park 《American journal of transplantation》2007,7(4):857-863
The immunologic risk associated with donor-specific antibodies (DSA) against Class II human leukocyte antigens (HLA) in kidney transplant (KTx) recipients is unclear. The aim of this study was to determine the outcome of KTx when DSA was detected only against HLA Class II. To isolate the impact of anti-Class II DSA, we retrospectively analyzed 12 KTx recipients who at baseline had a positive B-cell flow cytometric crossmatch (FXM) and a negative T-cell FXM. Using alloantibody specification analysis, 58.3% (7/12) had DSA against donor Class II and 41.7% had no demonstrable DSA. Biopsy-proven AMR occurred in 57% (4/7) in the Class II(+) group and 0% in the Class II(-) group (p > 0.05). Peritubular capillaries stained positive for C4d in 86% (6/7) of the Class II(+) patients and in 40% (2/5) of the Class II(-) patients (p > 0.05). One patient in the Class II(+) group lost their graft at 3 months to accelerated transplant glomerulopathy, while all other grafts were functioning 3-37 months posttransplant despite the persistence of anti-Class II DSA. We conclude that KTx recipients with clearly defined anti-Class II DSA are at risk for humoral rejection suggesting that desensitization and/or close posttransplant monitoring may be needed to prevent AMR. 相似文献
33.
左旋布比卡因复合舒芬太尼或芬太尼在分娩硬膜外自控镇痛的应用 总被引:1,自引:0,他引:1
目的探讨左旋布比卡因复合舒芬太尼硬膜外自控镇痛(PCEA)用于分娩镇痛的临床效果及安全性。方法随机选择120例美国标准协会(ASA)I-Ⅱ级初产妇,随机分为舒芬太尼组(A组)、芬太尼组(B组)、无镇痛组(C组),每组40例。A组和B组采用PCEA,C组不给予镇痛药物。观察各组不同时段视觉模拟评分(VAS)和不良反应的发生,同时记录3组产程时间、分娩方式、缩宫使用情况、产后出血量、新生儿Apgar评分。结果A、B2组和C组在PCEA20、60min及宫口开全时VAS差异有统计学意义(P〈0.05);PCEA5min,A、B2组VAS差异有统计学意义(P〈0.05),2组Bromage评分、不良反应差异无统计学意义(P〉0.05)。3组产程时间、分娩方式、产后出血量、新生儿Apgar评分比较差异均无统计学意义(P〉0.05)。结论左旋布比卡因复合舒芬太尼或芬太尼用于分娩镇痛安全有效,对母婴无明显不良影响。 相似文献
34.
Tick-borne encephalitis (TBE) virus is an important human pathogenic flavivirus that is endemic in Europe and Asia. The disease can be effectively prevented by inactivated vaccines and vaccination breakthroughs (VBTs) are rare. We investigated the characteristics of antibody responses in such VBTs in comparison to those in unvaccinated TBE patients. In contrast to the unvaccinated controls, most of the VBTs displayed a delayed IgM antibody response and had high avidity and strongly neutralizing antibodies already in the first sample taken upon hospitalization. The antibody profile of these patients therefore had the characteristics of an anamnestic immune response. In the VBTs analyzed, immunological priming and memory were apparently not sufficient or fast enough to prevent the disease. 相似文献
35.
Christian J. Sauder Cheryl X. Zhang Malen A. Link W. Paul Duprex Kathryn M. Carbone Steven A. Rubin 《Vaccine》2009
The recent global resurgence of mumps has drawn attention to the continued need for robust mumps immunization programs. Unfortunately, some vaccines derived from inadequately attenuated vaccine strains of mumps virus have caused meningitis in vaccinees, leading to withdrawal of certain vaccine strains from the market, public resistance to vaccination, or in some cases, cessation of national mumps vaccination programs. The most widely implicated mumps vaccine in cases of postvaccination meningitis is derived from the Urabe AM9 strain, which remains in use in some countries. The Urabe AM9 vaccine virus has been shown to exhibit a considerable degree of nucleotide and amino acid heterogeneity. Some studies have specifically implicated variants containing a lysine residue at amino acid position 335 in the hemagglutinin-neuraminidase (HN) protein with neurotoxicity, whereas a glutamic acid residue at this position was associated with attenuation. To test this hypothesis we generated two modified Urabe AM9 cDNA clones coding either for a lysine or a glutamic acid at position 335 in the HN gene. The two viruses were rescued by reverse genetics and characterized in vitro and in vivo. Both viruses exhibited similar growth kinetics in neuronal and non-neuronal cell lines and were of similar neurotoxicity when tested in rats, suggesting that amino acid 335 is not a crucial determinant of Urabe AM9 growth or neurovirulence. 相似文献
36.
37.
Chandipura virus (CHPV) has emerged as an important pediatric encephalitis-causing pathogen with very high mortality in India. No specific vaccine or treatment is available till date. We attempted to prepare a candidate vaccine employing recombinant CHPV Glycoprotein (rGp). The Glycoprotein gene (G-gene) of CHPV was expressed using Baculovirus expression system. The rGp was purified by HPLC and used for mice immunization, 3 doses, and 4 weeks apart. One microgram rGp was found to be optimum. Sero-conversion was observed as early as 2nd week by detecting anti-CHPV IgG antibodies. Antibody titres were immunogen-concentration dependent. Intracerebral challenge of the immunized mice with 100 LD50 of the homologous strain demonstrated 90% protection. In in vitro neutralization, antibodies from the immunized mice were able to neutralize heterologous viruses. There was 60% T cell proliferation observed against rGp in immunized mice. The study shows that rGp induces both arms of immune response and represents an ideal vaccine candidate for further evaluations. 相似文献
38.
39.
40.
目的研究原癌基因c-myc和jun在人胎冠状动脉发育过程中的表达与平滑肌细胞增殖的关系.方法用原位杂交方法检测,胎龄分别为16周、22周(因治疗需要引产)的胎儿和意外死亡的足月胎儿冠状动脉前降支c-myc mRNA和jun mRNA的表达水平.杂交反应产物用图像分析仪(MIAS300)作定量分析.结果C-myc mRNA原位杂交反应产物与被测血管区域面积的百分比在16周、22周和足月胎儿分别是70、56和10;Jun mRNA的杂交信反应产物与被测血管区域面积的百分比在这三个时期分别是68、53和8.两个原癌基因在不同阶段的表达均具有显著性差异.结论本实验首次报道c-myc和jun在人胎冠状动脉发育过程中平滑肌的表达图型,c-myc和jun在胎儿冠状动脉平滑肌细胞增殖和内膜的形成过程中可能具有重要的调控作用. 相似文献